etanercept Archives - Medical Conferences

Convincingly low levels of infections with long-term tildrakizumab

Trial

reSURFACE 1 and 2

Conference

AAD VMX 2021

7 June, 2021 13:15

Selective IL-23 blocker safe in elderly psoriasis patients

Presented By

Prof. Peter van de Kerkhof, Radboudumc, the Netherlands

Trial

reSURFACE

Conference

AAD 2020

19 August, 2020 13:18

Psoriasis therapy for children and pregnancies

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

CRIB, CADMUS, IXORA-PEDS

Conference

AAD 2020

6 August, 2020 08:03

TNFi for RA during pregnancy – to stop or not to stop?

Presented By

Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany

Conference

ACR 2019

4 February, 2020 10:16

Biologics: increasingly used in paediatric dermatology

Presented By

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Conference

EADV 2019

9 December, 2019 15:16

Etanercept and methotrexate as first-line treatment in PsA

Presented By

Prof. Philip Mease, University of Washington, USA

Trial

Phase 3, SEAM-PsA

Conference

EULAR 2019

4 September, 2019 10:40

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial

TARGET

Conference

EULAR 2018

24 August, 2018 19:30

Combining new drugs with different mechanisms

Trial

EXPLORER

Conference

ECCO 2018

28 May, 2018 23:31